Alivus Life Sciences Ltd. (GLS)
Market Closed
12 Aug, 10:00
XNSE MSE Primary XNSE ₹
1,361. 00
-32.6
-2.3393%
₹
- Market Cap
- P/E Ratio
- Div Yield
82,193 Volume
- Eps
₹ 1,393.6
Previous Close Want to track GLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alivus Life Sciences Ltd. (GLS) Statistics
Valuation metrics
Market Cap -
Enterprise value 163.76B
Trailing P/E (ttm) 27.07
Forward P/E -
PEG ratio 1.26
Price/Sales (ttm) 6.3
Price/Book (mrq) 4.9
Enterprise Value/Revenue 6.32
Enterprise Value/EBITDA 18.73
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 289.46K
Average volume (90 days) 115.01K
Price summary
52-Week low 819
52-Week high 1,418
Beta -
50-Day moving average 1,151.94
200-Day moving average 1,032.13
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.23%
Operating margin 0.29%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 211.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 49.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 63.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 5.21%
Book value per share (mrq) 271.48
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
